NEW YORK (GenomeWeb) — Chinese startup Cure Genetics announced today that it has raised $17 million in a Series A financing round. The round was led by Qiming Venture Partners and included investments from CTS Capital and Ascendin Investment.
China - based Cure Genetics has raised $ 500 million in series A funding , led by venture Venture Partners , with investment from CTS Capital and Ascendin Investment . The start - up , which uses gene editing to develop cellular and molecular diagnostics , will use the funds to improve its technology capabilities , to fund regulatory filings and clinical trials , and to expand its pipeline .